Persistent nausea and anorexia after marrow transplantation: A prospective study of 78 patients

Transplantation

Volumn 66, Issue 10, 1998, Pages 1319-1324

  Wu, Danny ^a   Hockenbery, David M ^a   Brentnall, Teresa A ^a   Baehr, Paul H ^a   Ponec, Robert J ^a   Kuver, Rahul ^a   Tzung, Shie Pon ^a   Todaro, Jane L ^a   McDonald, George B ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PREDNISONE;

ADOLESCENT; ADULT; ANOREXIA; ARTICLE; BONE MARROW TRANSPLANTATION; CHILD; CLINICAL ARTICLE; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HERPES VIRUS; HLA MATCHING; HUMAN; INTESTINE BIOPSY; MALE; NAUSEA; PARENTERAL NUTRITION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; VIRUS CULTURE; VOMITING;

EID: 0032573420     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199811270-00010     Document Type: Article

References (44)

1. Strasser SI, McDonald GB. Gastrointestinal and hepatic complications. In: Thomas ED, Forman SJ, Blume KG, eds. Hematopoietic cell transplantation. Cambridge, MA: Blackwell Scientific Publications, 1998; in press.
2. Epstein RJ, McDonald GB, Sale GE, Shulman HM, Thomas ED. The diagnostic accuracy of the rectal biopsy in graft-versus-host disease: a prospective study of thirteen patients. Gastroenterology 1980; 78: 764.
3. Spencer GD, Shulman HM, Myerson D, Thomas ED, McDonald GB. Diffuse intestinal ulceration after marrow transplantation: a clinical-pathological study of 13 patients. Hum Pathol 1986; 17: 621.
4. McDonald GB, Sharma P, Hackman RC, Meyers JD, Thomas ED. Esophageal infections in immunosuppressed patients after marrow transplantation. Gastroenterology 1985; 88: 1111.
5. Cox GJ, Matsui SM, Lo RS, et al. Etiology and outcome of diarrhea after marrow transplantation: a prospective study. Gastroenterology 1994; 107: 1398.
6. Ferrara JLM, Cooke KR, Pan L, Krenger W. The immunopathophysiology of acute graft-versus-host-disease. Stem Cells 1996; 14: 473.
7. Sullivan, KM. Graft-versus-host disease. In: Thomas ED, Forman SJ, Blume KG, eds. Hematopoietic cell transplantation. Cambridge, MA: Blackwell Scientific Publications, 1998; in press.
8. Spencer GD, Hackman RC, McDonald GB, et al. A prospective study of unexplained nausea and vomiting after marrow transplantation. Transplantation 1986; 42: 602.
9. Weisdorf DJ, Snover DC, Haake R, et al. Acute upper gastrointestinal graft-versus-host disease: clinical significance and response to immunosuppressive therapy. Blood 1990; 76: 624.
10. Snover DC. Graft-versus-host disease of the gastrointestinal tract. Am J Surg Pathol 1990; 14 (suppl. 1): 101.
11. McDonald G.B, Sale GE. The human gastrointestinal tract after allogeneic marrow transplantation. In: Sale GE, Shulman HM, eds. The pathology of bone marrow transplantation. New York: Masson, 1984: 77.
12. Przepiorka D, Weisdorf D, Martin P, et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995; 15: 825.
13. Otero Lopez-Cubero S, Sale GE, McDonald GB. Acute graft-versus-host disease of the esophagus. Endoscopy 1997; 29: S35.
14. Aker SN, Lenssen P. Nutritional support of patients with hematologic malignancies. In: Hoffman R, Benz EJ, Shattil SJ, Furie B, Cohen HJ, Siberstein LE, eds. Hematology: basic principles and practice. New York: Churchill Livingstone, 1995: 1473.
15. Charuhas PM, Fosberg KL, Bruemmer B, et al. A double-blind randomized trial comparing outpatient parenteral nutrition with intravenous hydration: effect on resumption of oral intake after marrow transplantation. J Parenter Enteral Nutr 1997; 21: 157.
16. Roy J, Snover DC, Weisdorf S, Mulvahill A, Filipovich A, Weisdorf D. Simultaneous upper and lower endoscopic biopsy in the diagnosis of intestinal graft-versus-host disease. Transplantation 1991; 51: 642.
17. Snover DC, Weisdorf SA, Vercellotti GM, Rank B, Hutton S, McGlave P. A histopathologic study of gastric and small intestine graft-versus-host disease following allogeneic bone marrow transplantation. Hum Pathol 1985; 16: 387.
18. Washington K, Bentley RC, Green A, Olson J, Treem KR and Krigman HK. Gastric graft-versus-host disease: a blinded histologic study. Am J Surg Pathol 1997; 21: 1037.
19. Boeckh M, Myerson D, Bowden RA. Early detection and treatment of cytomegalovirus infections in marrow transplant patients: methodological aspects and implications for therapeutic interventions [Review]. Bone Marrow Transplant 1994; 14: S66.
20. Boeckh M, Gooley TA, Myerson D, Cunningham T, Schoch G, Bowden RA. Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: a randomized double-blind study. Blood 1996; 88: 4063.
21. Beatty PG, Anasetti C, Hansen JA, et al. Marrow transplantation from unrelated donors for treatment of hematologic malignancies: effect of mismatching for one HLA locus. Blood 1993; 81: 249.
22. Kernan NA, Bartsch G, Ash RC, et al. Analysis of 462 transplantations from unrelated donors facilitated by the national marrow donor program. N Engl J Med 1993; 328: 593.
23. Thomas ED, Forman SJ, Blume KG. Hematopoietic cell transplantation, 2nd Ed. Cambridge, MA: Blackwell Scientific Publications, 1998; in press.
24. Bensinger, W, Buckner, CD. Preparative regimens. In: Thomas ED, Forman SJ, Blume KG, eds. Hematopoietic cell transplantation. Cambridge, MA: Blackwell Scientific Publications, 1998; in press.
25. Storb R, Deeg HJ, Whitehead J, et al. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft-versus-host disease after bone marrow transplantation for leukemia. N Engl J Med 1986; 314: 729.
26. Harris JA, Benedict FG. Biometric studies of basal metabolism in man. Carnegie Institution of Washington 1919; Publication 279.
27. Martin PJ, Schoch G, Fisher L, et al. A retrospective analysis of therapy for acute graft-versus-host disease: initial treatment. Blood 1990; 76: 1464.
28. Hackman RC, Wolford JL, Gleaves CA, et al. Recognition and rapid diagnosis of upper gastrointestinal cytomegalovirus infection in marrow transplant recipients: a comparison of seven virologic methods. Transplantation 1994; 57: 231.
29. Baehr PH, McDonald GB. Esophageal infections: risk factors, presentation, diagnosis, and treatment. Gastroenterology 1994; 106: 509.
30. Baehr PH, Levine DS, Bouvier ME, et al. Oral beclomethasone dipropionate for treatment of human intestinal graft-versus-host disease. Transplantation 1995; 60: 1231.
31. McDonald GB, Bouvier M, Hockenbery DM, et al. Oral beclomethasone dipropionate for treatment of intestinal graft-versus-host disease: a randomized, placebo-controlled trial. Gastroenterology 1998; 115: 28.
32. Kennedy MJ, Jones RJ. Autologous graft-versus-host disease: immunotherapy of breast cancer after bone marrow transplantation. Breast Cancer Res Treatment 1993; 26: S31.
33. Einsele H, Ehninger G, Schneider EM, Kruger GFR, Vallbracht A, Dopfer R, Schmidt H, Waller HD, Muller CA. High frequency of graft-versus-host-like syndromes following syngeneic bone marrow transplantation. Transplantation 1988; 45: 579-585.
34. Tzung S-P, Hackman RC, Hockenbery DM, Bensinger W, Schiffman K, McDonald GB. Lymphocytic gastritis resembling graft-vs.-host disease following autologous hematopoietic cell transplantation. Biol Blood Marrow Transplant 1998; 4: 43.
35. Ponec RJ, Hackman RC, McDonald GB. Endoscopie and histologic diagnosis of intestinal graft-vs.-host disease after marrow transplantation. Gastrointest Endosc 1998; in press.
36. Murakami CS, Chan GS, McDonald GB. Incidence and etiology of extrahepatic biliary obstruction in bone marrow transplant patients [Abstract]. Gastroenterology 1997; 112: A1340.
37. Wolford JL, McDonald GB. Intramural hematomas of esophagus, stomach and small intestine in marrow transplant patients [Abstract]. Gastroenterology 1988; 94: A501.
38. Lipson SA, Perr HA, Koerper MA, Ostroff JW, Snyder JD, Goldstein RB. Intramural duodenal hematoma after endoscopic biopsy in leukemic patients. Gastrointest Endosc 1996; 44: 620.
39. Zaia, J. Cytomegalovirus infection. In: Thomas ED, Forman SJ, Blume KG, eds. Hematopoietic cell transplantation. Cambridge, MA: Blackwell Scientific Publications, 1998; in press.
40. Goodman JL, Winston DJ, Greenfield RA, et al. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N Engl J Med 1992; 326: 845.
41. Slavin MA, Osborne B, Adams R, et al. Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation: a prospective, randomized, double-blind study. J Infect Dis 1995; 171: 1545.
42. van Burik JH, Leisenring W, Myerson D, et al. The effect of prophylactic fluconazole on the clinical spectrum of fungal diseases in bone marrow transplant recipients with special attention to hepatic candidiasis: an autopsy study of 355 patients. Medicine (Baltimore) 1998; 77: 246.
43. Kernan, N.A. T-cell depletion for prevention of graft-versus-host disease. In: Thomas ED, Forman SJ, Blume KG, eds. Hematopoietic cell transplantation. Cambridge, MA: Blackwell Scientific Publications, 1998; in press.
44. Jaffe HS, Abrams DI, Ammann AJ, Lewis BJ, Golden JA. Complications of co-trimoxazole in treatment of AIDS-associated Pneumocystis carinii pneumonia in homosexual men. Lancet 1983; 2: 1109.